BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27411412)

  • 21. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
    Rigaud C; Knörr F; Brugières L; Woessmann W
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101444. PubMed ID: 36907641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaplastic large cell lymphoma in paediatric and young adult patients.
    Turner SD; Lamant L; Kenner L; Brugières L
    Br J Haematol; 2016 May; 173(4):560-72. PubMed ID: 26913827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
    Morel A; Brière J; Lamant L; Loschi M; Haioun C; Delarue R; Tournilhac O; Bachy E; Sonet A; Amorim S; Laurent C; Gaulard P; Tilly H; Sibon D
    Eur J Cancer; 2017 Sep; 83():146-153. PubMed ID: 28735072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric anaplastic large cell lymphoma with leukaemic presentation in children: a report of nine French cases.
    Spiegel A; Paillard C; Ducassou S; Perel Y; Plantaz D; Strullu M; Eischen A; Lutz P; Lamant L; Le Deley MC; Brugières L
    Br J Haematol; 2014 May; 165(4):545-51. PubMed ID: 24666317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan.
    Mori T; Takimoto T; Katano N; Kikuchi A; Tabuchi K; Kobayashi R; Ayukawa H; Kumagai MA; Horibe K; Tsurusawa M
    Br J Haematol; 2006 Mar; 132(5):594-7. PubMed ID: 16445832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcome of Chinese children with anaplastic large cell lymphoma by using a modified B-NHL-BFM-90 protocol.
    Sun X; Zhen Z; Lin S; Zhu J; Wang J; Lu S; Chen Y; Zhang F; Sun F; Li P
    Pediatr Hematol Oncol; 2014 Sep; 31(6):518-27. PubMed ID: 25116372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma.
    Sandlund JT; Pui CH; Santana VM; Mahmoud H; Roberts WM; Morris S; Raimondi S; Ribeiro R; Crist WM; Lin JS
    J Clin Oncol; 1994 May; 12(5):895-8. PubMed ID: 8164039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Factors and Treatment Outcome of Pediatric Anaplastic Large Cell Lymphoma Treated at the Children Cancer Hospital Egypt.
    Abdel Rahman H; El Semary S; Sedky M; Atteya I; El Kinaaie N; El Wakeel M; Hassanein O; Mohy R
    J Pediatr Hematol Oncol; 2019 Oct; 41(7):e427-e431. PubMed ID: 31343479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres.
    Longo G; Federico M; Pieresca C; Avanzini P; Iannitto E; Di Prisco AU; Baldini L; Brugiatelli M; Clò V; Bevini M
    Eur J Cancer; 1995 Oct; 31A(11):1763-7. PubMed ID: 8541096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy - ten years experience from a tertiary care center in a LMIC.
    Trivedi M; Thankamony P; Nair M; Rajeswari B; Guruprasad CS; Prasanth VR; Nair RA; Jagathnath Krishna KM
    Pediatr Hematol Oncol; 2023; 40(5):485-496. PubMed ID: 37477212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.
    Mitou G; Frentzel J; Desquesnes A; Le Gonidec S; AlSaati T; Beau I; Lamant L; Meggetto F; Espinos E; Codogno P; Brousset P; Giuriato S
    Oncotarget; 2015 Oct; 6(30):30149-64. PubMed ID: 26338968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].
    Wróbel G; Kazanowska B; Chybicka A; Jeleń M; Małdyk J; Sowińska E; Balcerska A; Balwierz W; Bubała H; Kołakowska-Mrozowska B; Kołtan A; Korzon M; Kowalczyk J; Krawczuk-Rybak M; Maciejka-Kapuścińska L; Matysiak M; Płoszyńska A; Popadiuk S; Solarz E; Sońta-Jakimczyk D; Sopyło B; Stańczak E; Stefaniak J; Stefańska K; Wachowiak J; Wieczorek M; Wysocki M
    Przegl Lek; 2004; 61 Suppl 2():45-8. PubMed ID: 15686045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
    Lin XB; Jiang WQ; Zhong XY; Luo RZ
    Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features and prognosis for anaplastic large cell lymphoma].
    Dong F; Liu Y; Li Q; Wang J; Jing H; Ke X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 43(6):631-637. PubMed ID: 30110005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous anaplastic large cell lymphoma.
    Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
    Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High-dose polychemotherapy of patients with poor-prognosis anaplastic T.0-large cell ALK+ lymphosarcoma].
    Aitova LG; Vinogradova IuE; Kaplanskaia IB; Lutsenko IN; Zvonkov EE; Momotiuk KS; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2009; 81(7):53-7. PubMed ID: 19708574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series.
    Ruf S; Hebart H; Hjalgrim LL; Kabickova E; Lang P; Steinbach D; Schwabe GC; Woessmann W
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27003. PubMed ID: 29512859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
    Vinogradova IuE; Lutsenko IN; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Gorgidze LA; Ryzhikova NA; Valiev TT; Giliazitdinova EA; Dzhulakian UL; Egorova EK; Zvonkov EE; Krasil'nikova BB; Magomedova AU; Margolin OV; Mar'in DS; Kremenetskaia AM; Kravchenko SK; Vorob'ev AI
    Ter Arkh; 2008; 80(7):33-7. PubMed ID: 18763592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.